Abstract
Purpose
The rapid growth of semaglutide use for weight loss has been accompanied by a proliferation of patient-shared experiences and non-evidence-based claims on video platforms. This unchecked information environment poses significant risks to public health, including potential self-medication and misunderstanding of treatment risks, underscoring the urgent need to evaluate the quality of semaglutide-related video content to safeguard digital health literacy. This study assesses the quality, reliability, and user engagement of semaglutide-related short videos on TikTok and Bilibili.
Approach
This cross-sectional study analyzed the top 100 semaglutide-related videos from TikTok and Bilibili, using keyword searches. Videos were evaluated using JAMA benchmark criteria, Global Quality Scale (GQS), and DISCERN tools.
Setting
Retrieving top 100 videos from TikTok (Mar 4, 2025) and Bilibili (Mar 8, 2025) using “司美格鲁肽” (Semaglutide) as the search keyword.
Participants
200 videos and their characteristics.
Results
Among 200 videos, no statistically significant inter-platform differences in JAMA, GQS or DISCERN scores were observed. Non-professional organizations achieved higher JAMA scores than individual creators (P < .01). Medical information videos scored higher than personal experience content (P < .0001). Engagement metrics (likes) correlated weakly with quality (r = 0.151, P < .05), while longer videos were associated with higher DISCERN scores (r = 0.273, P < .001) but not increased engagement.
Conclusions
Semaglutide-related videos on TikTok and Bilibili show moderate quality, with medical professionals and institutions producing more reliable content. However, user engagement remains a poor indicator of quality. These findings call for platform governance to algorithmically promote evidence-based content and verify credible creators, while public health efforts should steer user attention from popularity to credibility, thereby protecting informed decision-making.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
